CHIMIA
(Feb 2024)
The Evolving Landscape of Neuroscience Therapeutics: an Interplay of Multiple Modalities
- Hendrik Knoetgen,
- Torsten Schindler,
- Felix F. Schumacher,
- Antonia F. Stepan,
- Alain C. Tissot,
- Jaclyn I. Wamsteeker Cusulin
Affiliations
- Hendrik Knoetgen
- Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. HoffmannLa Roche AG, 4070 Basel, Switzerland
- Torsten Schindler
- Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. HoffmannLa Roche AG, 4070 Basel, Switzerland
- Felix F. Schumacher
- Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. HoffmannLa Roche AG, 4070 Basel, Switzerland
- Antonia F. Stepan
- Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. HoffmannLa Roche AG, 4070 Basel, Switzerland
- Alain C. Tissot
- Roche Pharma Research and Early Development, Roche Innovation Center Munich, Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany
- Jaclyn I. Wamsteeker Cusulin
- Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. HoffmannLa Roche AG, 4070 Basel, Switzerland
- DOI
-
https://doi.org/10.2533/chimia.2024.62
- Journal volume & issue
-
Vol. 78,
no. 1/2
WeChat QR code